Novartis to put AveXis into protective custody after data manipulation scandal

Big Pharma's traditional hands-off approach led to a serious credibility issue for Novartis as a data manipulation scandal has unfolded at gene therapy biotech AveXis. Going forward, Novartis says, it will be hands-off no longer.